147 related articles for article (PubMed ID: 23324020)
1. Taste masking of naproxen sodium granules by fluid-bed coating.
Stange U; Führling C; Gieseler H
Pharm Dev Technol; 2014 Mar; 19(2):137-47. PubMed ID: 23324020
[TBL] [Abstract][Full Text] [Related]
2. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
4. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
Maghsoodi M
AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
6. [Taste-masking possibilities in solid dosage forms].
Szakonyi G; Zelkó R
Acta Pharm Hung; 2012; 82(2):81-90. PubMed ID: 22870781
[TBL] [Abstract][Full Text] [Related]
7. Original research paper. Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying.
Amelian A; Szekalska M; Ciosek P; Basa A; Winnicka K
Acta Pharm; 2017 Mar; 67(1):113-124. PubMed ID: 28231047
[TBL] [Abstract][Full Text] [Related]
8. Formulation and development of oral dry suspension using taste masked Ornidazole particles prepared using Kollicoat(®) Smartseal 30 D.
Chivate A; Sargar V; Nalawade P; Tawde V
Drug Dev Ind Pharm; 2013 Jul; 39(7):1091-7. PubMed ID: 22900982
[TBL] [Abstract][Full Text] [Related]
9. Taste masking of enalapril maleate by microencapsulation in Eudragit EPO
Georgieva Y; Kassarova M; Kokova V; Apostolova E; Pilicheva B
Pharmazie; 2020 Mar; 75(2):61-69. PubMed ID: 32213236
[TBL] [Abstract][Full Text] [Related]
10. Film coatings for taste masking and moisture protection.
Joshi S; Petereit HU
Int J Pharm; 2013 Dec; 457(2):395-406. PubMed ID: 24148666
[TBL] [Abstract][Full Text] [Related]
11. Bitter-blockers as a taste masking strategy: A systematic review towards their utility in pharmaceuticals.
Andrews D; Salunke S; Cram A; Bennett J; Ives RS; Basit AW; Tuleu C
Eur J Pharm Biopharm; 2021 Jan; 158():35-51. PubMed ID: 33130339
[TBL] [Abstract][Full Text] [Related]
12. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
13. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration.
Lopalco A; Denora N; Laquintana V; Cutrignelli A; Franco M; Robota M; Hauschildt N; Mondelli F; Arduino I; Lopedota A
Int J Pharm; 2020 Jan; 574():118922. PubMed ID: 31836482
[TBL] [Abstract][Full Text] [Related]
14. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
Nakano Y; Maeda A; Uchida S; Namiki N
Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
[TBL] [Abstract][Full Text] [Related]
16. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
[TBL] [Abstract][Full Text] [Related]
17. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms.
Arima H; Higashi T; Motoyama K
Ther Deliv; 2012 May; 3(5):633-44. PubMed ID: 22834407
[TBL] [Abstract][Full Text] [Related]
19. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
Ruckmani K; Muneera MS; Vijaya R
Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
[TBL] [Abstract][Full Text] [Related]
20. Building Process Understanding of Fluid Bed Taste Mask Coating of Microspheres.
Silva BS; Santangelo M; Colbert MJ; Fauteux-Lefebvre C; Bartlett JA; Lapointe-Garant PP; Gosselin R
AAPS PharmSciTech; 2019 Apr; 20(5):173. PubMed ID: 31020426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
